These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 3266294)
1. The activation of C3 and C4 in human serum by immune complexes containing mouse monoclonal antibodies of different isotype and affinity: effects on solubilisation. Stewart WW; Johnson A; Steward MW; Whaley K; Kerr MA Mol Immunol; 1988 Dec; 25(12):1355-61. PubMed ID: 3266294 [TBL] [Abstract][Full Text] [Related]
2. The effect of antibody isotype on the activation of C3 and C4 by immune complexes formed in the presence of serum: correlation with the prevention of immune precipitation. Stewart WW; Johnson A; Steward MW; Whaley K; Kerr MA Mol Immunol; 1990 May; 27(5):423-8. PubMed ID: 2366759 [TBL] [Abstract][Full Text] [Related]
3. Clonal variations in complement activation and deposition of C3b and C4b on model immune complexes. Yokoyama I; Waxman F Immunology; 1993 Oct; 80(2):168-76. PubMed ID: 8262546 [TBL] [Abstract][Full Text] [Related]
4. The effects of immunoglobulin isotype and antibody affinity on complement-mediated inhibition of immune precipitation and solubilization. Johnson A; Harkin S; Steward MW; Whaley K Mol Immunol; 1987 Nov; 24(11):1211-7. PubMed ID: 3696168 [TBL] [Abstract][Full Text] [Related]
5. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a). Schifferli JA; Steiger G; Paccaud JP Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858 [TBL] [Abstract][Full Text] [Related]
6. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes. Miletic VD; Hester CG; Frank MM J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829 [TBL] [Abstract][Full Text] [Related]
7. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions. Lucisano Valim YM; Lachmann PJ Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767 [TBL] [Abstract][Full Text] [Related]
9. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer. Langone JJ; Das C; Bennett D; Terman DS J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of antigen complexed with antibody. I. Role of different isotypes. Farkas AI; Medgyesi GA; Füst G; Miklós K; Gergely J Immunology; 1982 Mar; 45(3):483-92. PubMed ID: 7061107 [TBL] [Abstract][Full Text] [Related]
11. Binding to erythrocyte complement receptor type 1 of BSA/anti-BSA complexes opsonized by C4A3 or C4B1 in the presence of serum. Klint C; Truedsson L; Sturfelt G Scand J Immunol; 1995 Oct; 42(4):425-32. PubMed ID: 7569775 [TBL] [Abstract][Full Text] [Related]
12. Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activation. Pluschke G; Bordmann G; Daoudaki ME; Lambris JD; Achtman M; Neibert M Eur J Immunol; 1989 Jan; 19(1):131-5. PubMed ID: 2646134 [TBL] [Abstract][Full Text] [Related]
13. Isotypic and clonal variations in the interactions between model monoclonal immune complexes and the human erythrocyte CR1 receptor. Yokoyama I; Waxman F Mol Immunol; 1992; 29(7-8):935-47. PubMed ID: 1386141 [TBL] [Abstract][Full Text] [Related]
14. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q. Bindon CI; Hale G; Brüggemann M; Waldmann H J Exp Med; 1988 Jul; 168(1):127-42. PubMed ID: 3260935 [TBL] [Abstract][Full Text] [Related]
15. Complement activation by immunoglobulin does not depend solely on C1q binding. Bindon CI; Hale G; Waldmann H Eur J Immunol; 1990 Feb; 20(2):277-81. PubMed ID: 2311645 [TBL] [Abstract][Full Text] [Related]
16. Activation of effector functions by immune complexes of mouse IgG2a with isotype-specific autoantibodies. Rajnavölgyi E; Fazekas G; Lund J; Daeron M; Teillaud JL; Jefferis R; Fridman WH; Gergely J Immunology; 1995 Apr; 84(4):645-52. PubMed ID: 7540592 [TBL] [Abstract][Full Text] [Related]
17. Complement activation in experimental IgA nephropathy: an antigen-mediated process. Rifai A; Chen A; Imai H Kidney Int; 1987 Dec; 32(6):838-44. PubMed ID: 3430967 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of immune precipitation by complement. Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294 [TBL] [Abstract][Full Text] [Related]
19. Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes. Pfaffenbach G; Lamm ME; Gigli I J Exp Med; 1982 Jan; 155(1):231-47. PubMed ID: 7054357 [TBL] [Abstract][Full Text] [Related]
20. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition. Ziccardi RJ J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]